Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11032 results:
[ Συντάκτης(Desc)] Τίτλος Τύπος Έτος
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
T
Touvra, A-M., Volaklis K. A., Spassis A. T., Zois C. E., Douda H. D., Kotsa K., et al. (2011).  Combined strength and aerobic training increases transforming growth factor-β1 in patients with type 2 diabetes.. Hormones (Athens). 10(2), 125-30.
Trachana, M., Pratsidou-Gertsi P., Badouraki M., Haidich A. Bettina, & Pardalos G. (2013).  Achievement of clinical remission in patients with juvenile idiopathic arthritis under a 2-10-year Etanercept exposure.. Clin Rheumatol. 32(8), 1191-7.
Trachana, V., Petrakis S., Fotiadis Z., Siska E. K., Balis V., Gonos E. S., et al. (2017).  Human mesenchymal stem cells with enhanced telomerase activity acquire resistance against oxidative stress-induced genomic damage.. Cytotherapy. 19(7), 808-820.
Trachana, M., Pratsidou-Gertsi P., Kanakoudi-Tsakalidou F., Tzimouli V., Printza N., & Papachristou F. (2020).  Impact of the longitudinal quantitative assessment of juvenile systemic lupus erythematosus severity on the disease outcome.. Clin Rheumatol.
Trachana, M., Pratsidou-Gertsi P., Pardalos G., Kozeis N., Badouraki M., & Kanakoudi-Tsakalidou F. (2011).  Safety and efficacy of adalimumab treatment in Greek children with juvenile idiopathic arthritis.. Scand J Rheumatol. 40(2), 101-7.
Trachana, M., Pratsidou-Gertsi P., Kanakoudi-Tsakalidou F., Christodoulou A., Bantouraki M., Arsos G., et al. (2008).  Secondary osteonecrosis mimicking a femur bone tumor in an adolescent with juvenile idiopathic arthritis.. Pediatr Blood Cancer. 51(1), 151-2.
Trachana, M., Koutsonikoli A., Farmaki E., Printza N., Tzimouli V., & Papachristou F. (2013).  Safety and efficacy of rituximab in refractory pediatric systemic lupus erythematosus nephritis: a single-center experience of Northern Greece.. Rheumatol Int. 33(3), 809-13.
Tragiannidis, A., Kyriakidis I., ündorf I., & Groll A. H. (2017).  Invasive fungal infections in pediatric patients treated with tumor necrosis alpha (TNF-α) inhibitors. Mycoses. 60229305262225245129365386(4Suppl 3Suppl 3), 222 - 229.
Tragiannidis, A., Roilides E., Walsh T. J., & Groll A. H. (2012).  Invasive aspergillosis in children with acquired immunodeficiencies.. Clin Infect Dis. 54(2), 258-67.
Tragiannidis, A., Dokos C., Koliouskas D., & Athanasiadou F. (2012).  BMI alterations during treatment of childhood ALL.. Pediatr Blood Cancer. 58(6), 1001.
Tragiannidis, A., Kyriakidis I., Zündorf I., & Groll A. H. (2017).  Invasive fungal infections in pediatric patients treated with tumor necrosis alpha (TNF-α) inhibitors.. Mycoses. 60(4), 222-229.
Tragiannidis, A., Tsoulas C., & Groll A. H. (2015).  Invasive candidiasis and candidaemia in neonates and children: update on current guidelines.. Mycoses. 58(1), 10-21.
Tragiannidis, A., Pana Z. Dorothea, Papageorgiou T., Hatzipantelis E., Hatzistilianou M., & Athanassiadou F. (2011).  Transient myeloproliferative disorder in a newborn with down syndrome treated with rasburicase for the risk of development of tumor lysis syndrome: A case report.. J Med Case Rep. 5, 407.
Tragiannidis, A., Dokos C., Sidi V., Papageorgiou T., Koliouskas D., Karamouzis M., et al. (2011).  Alterations of bone mineral metabolism of children with different cell lineage types of acute lymphoblastic leukaemia under chemotherapy.. Hippokratia. 15(1), 43-7.
Tragiannidis, A., Vasileiou E., Papageorgiou M., Damianidou L., Hatzipantelis E., Gombakis N., et al. (2016).  Bone involvement at diagnosis as a predictive factor in children with acute lymphoblastic leukemia.. Hippokratia. 20(3), 227-230.
Tragiannidis, A., Tsoulas C., Kerl K., & Groll A. H. (2013).  Invasive candidiasis: update on current pharmacotherapy options and future perspectives.. Expert Opin Pharmacother. 14(11), 1515-28.
Tragiannidis, A., Papageorgiou M., Stamou M., Hatzipantelis E., Papageorgiou T., Giannopoulos A., et al. (2016).  Tumor lysis-like syndrome in a child during treatment for visceral leishmaniasis.. Int J Immunopathol Pharmacol. 29(3), 458-60.
Tragiannidis, A., Gombakis N., Papageorgiou M., Hatzipantelis E., Papageorgiou T., & Hatzistilianou M. (2016).  Treatment-related myelodysplastic syndrome (t-MDS)/acute myeloid leukemia (AML) in children with cancer: A single-center experience.. Int J Immunopathol Pharmacol. 29(4), 729-730.
Tragiannidis, A., üggen H., Ahlmann M., Vasileiou E., Gastine S., Thorer H., et al. (2019).  Plasma exposures following posaconazole delayed-release tablets in immunocompromised children and adolescentsAbstractBackgroundMethodsResultsConclusions. Journal of Antimicrobial Chemotherapy. 746 Suppl 1157349 Suppl 18356356122316563746471456105667716939884651303544581011432017595860293334100(12), 3573 - 3578.
Traianou, A., Ulrich M., Apalla Z., de Vries E., Bakirtzi K., Kalabalikis D., et al. (2012).  Risk factors for actinic keratosis in eight European centres: a case-control study.. Br J Dermatol. 167 Suppl 2, 36-42.
Trakada, G., Velentza L., Konsta A., Pataka A., Zarogoulidis P., & Dikeos D. (2017).  Complications of anesthesia during electroconvulsive therapy due to undiagnosed obstructive sleep apnea: A case-study.. Respir Med Case Rep. 20, 145-149.
Trakadis, Y. J., Alfares A., Bodamer O. A., Buyukavci M., Christodoulou J., Connor P., et al. (2014).  Update on transcobalamin deficiency: clinical presentation, treatment and outcome.. J Inherit Metab Dis. 37(3), 461-73.
Trakatelli, M., Barkitzi K., Apap C., Majewski S., & de Vries E. (2016).  Skin cancer risk in outdoor workers: a European multicenter case-control study.. J Eur Acad Dermatol Venereol. 30 Suppl 3, 5-11.
Trakatelli, M., Charalampidis S., Novakovic L. B., Patsatsi A., Kalabalikis D., & Sotiriadis D. (2009).  Photodermatoses with onset in the elderly.. Br J Dermatol. 161 Suppl 3, 69-77.
Trakatelli, M., Katsanos G., Ulrich C., Kalabalikis D., Sotiriadis D., & Stockfleth E. (2010).  Efforts to counteract locally the effects of systemic immunosupression: a review on the use of imiquimod, a topical immunostimulator in organ transplant recipients.. Int J Immunopathol Pharmacol. 23(2), 387-96.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές